Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa-Dependent Manner

Gastroenterology

Volumn 138, Issue 1, 2010, Pages

  Ahlenstiel, Golo ^a   Titerence, Rachel H ^a   Koh, Christopher ^a   Edlich, Birgit ^a   Feld, Jordan J ^a   Rotman, Yaron ^a   Ghany, Marc G ^a   Hoofnagle, Jay H ^a   Liang, T Jake ^a   Heller, Theo ^a   Rehermann, Barbara ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR BETA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2C; NATURAL KILLER CELL RECEPTOR NKP44; PROTEIN P44; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; BLOOD; CELL ACTIVATION; CELL FUNCTION; CELL POLARITY; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DEGRANULATION; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; LIVER; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 72549104093     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.08.066     Document Type: Article

References (43)

1. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5 (2005) 215-229
2. Urbani S., Amadei B., Fisicaro P., et al. Heterologous T cell immunity in severe hepatitis C virus infection. J Exp Med 201 (2005) 675-680
3. Lechner F., Wong D.K., Dunbar P.R., et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191 (2000) 1499-1512
4. Chang K.M., Thimme R., Melpolder J.J., et al. Differential CD4 and CD8 T-cell responsiveness in hepatitis C virus infection. Hepatology 33 (2001) 267-276
5. Lauer G.M., Barnes E., Lucas M., et al. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 127 (2004) 924-936
6. Wedemeyer H., He X.-S., Nascimbeni M., et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169 (2002) 3447-3458
7. Radziewicz H., Ibegbu C.C., Fernandez M.L., et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 81 (2007) 2545-2553
8. Rutebemberwa A., Ray S.C., Astemborski J., et al. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection. J Immunol 181 (2008) 8215-8225
9. Norris S., Collins C., Doherty D.G., et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 28 (1998) 84-90
10. McIntyre K.W., and Welsh R.M. Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection. J Exp Med 164 (1986) 1667-1681
11. Dunn C., Brunetto M., Reynolds G., et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 204 (2007) 667-680
12. Khakoo S.I., Thio C.L., Martin M.P., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305 (2004) 872-874
13. Paladino N., Flores A.C., Marcos C.Y., et al. Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus. Tissue Antigens 69 Suppl 1 (2007) 109-111
14. Ahlenstiel G., Martin M.P., Gao X., et al. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest 118 (2008) 1017-1026
15. Larkin J., Bost A., Glass J., et al. Cytokine-activated NK cells exert direct killing of hepatoma cells harboring hepatitis C virus replicons. J Interferon Cytokine Res 26 (2006) 854-865
16. Golden-Mason L., Madrigal-Estebas L., McGrath E., et al. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 57 (2008) 1121-1128
17. Morishima C., Paschal D.M., Wang C.C., et al. Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 43 (2006) 573-580
18. Nattermann J., Feldmann G., Ahlenstiel G., et al. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 55 (2006) 869-877
19. De Maria A., Fogli M., Mazza S., et al. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur J Immunol 37 (2007) 445-455
20. Oliviero B., Varchetta S., Paudice E., et al. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137 (2009) 1151-1160
21. Tseng C.T., and Klimpel G.R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 195 (2002) 43-49
22. Crotta S., Stilla A., Wack A., et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C Virus envelope protein. J Exp Med 195 (2002) 35-42
23. Yoon J.C., Shiina M., Ahlenstiel G., et al. Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology 49 (2009) 12-21
24. Alter G., Malenfant J.M., and Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294 (2004) 15-22
25. Fehniger T.A., Shah M.H., Turner M.J., et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 162 (1999) 4511-4520
26. Saez-Borderias A., Romo N., Magri G., et al. IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function. J Immunol 182 (2009) 829-836
27. Moretta L., Bottino C., Pende D., et al. Human natural killer cells: their origin, receptors and function. Eur J Immunol 32 (2002) 1205-1211
28. Biron C.A., Nguyen K.B., Pien G.C., et al. Natural killer cells in antiviral defence: function and regulation by innate cytokines. Annu Rev Immunol 17 (1999) 189-220
29. Miyagi T., Gil M.P., Wang X., et al. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. J Exp Med 204 (2007) 2383-2396
30. Meier U.C., Owen R.E., Taylor E., et al. Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J Virol 79 (2005) 12365-12374
31. Su A.I., Pezacki J.P., Wodicka L., et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A 99 (2002) 15669-15674
32. Bigger C.B., Brasky K.M., and Lanford R.E. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 75 (2001) 7059-7066
33. Shin E.C., Seifert U., Kato T., et al. Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. J Clin Invest 116 (2006) 3006-3014
34. Patzwahl R., Meier V., Ramadori G., et al. Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. J Virol 75 (2001) 1332-1338
35. Liang S., Wei H., Sun R., et al. IFNalpha regulates NK cell cytotoxicity through STAT1 pathway. Cytokine 23 (2003) 190-199
36. Mundt B., Wirth T., Zender L., et al. Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Gut 54 (2005) 1590-1596
37. Lan L., Gorke S., Rau S.J., et al. Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner. J Immunol 181 (2008) 4926-4935
38. Zhu H., Dong H., Eksioglu E., et al. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Gastroenterology 133 (2007) 1649-1659
39. Wang S.H., Huang C.X., Ye L., et al. Natural killer cells suppress full cycle HCV infection of human hepatocytes. J Viral Hepat 15 (2008) 855-864
40. Thimme R., Bukh J., Spangenberg H.C., et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 99 (2002) 15661-15668
41. Guidotti L.G., and Chisari F.V. To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 8 (1996) 478-483
42. Morandi B., Bougras G., Muller W.A., et al. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion. Eur J Immunol 36 (2006) 2394-2400
43. Feld J.J., Nanda S., Huang Y., et al. Hepatic gene expression during treatment with peginterferon and ribavirin: identifying molecular pathways for treatment response. Hepatology 46 (2007) 1548-1563